
A long-term bullish view on Tesla (TSLA) is supported by its perceived technological superiority and the future potential of its self-driving capabilities. Conversely, a strong bearish case exists for Beyond Meat (BYND), which faces significant headwinds from poor product perception and weak consumer demand. For the cannabis industry, the key catalyst to monitor is the potential federal rescheduling from Schedule 1 to Schedule 3, which would significantly de-risk the sector. Investors should be cautious with legacy automakers like Ford (F), as performance issues with key EV models like the F-150 Lightning could hinder their transition. Finally, the pharmaceutical sector faces major reputational and legal risks, especially for companies associated with opioids and SSRIs.